Dacogen

Active Ingredient(s): Decitabine
FDA Approved: * May 2, 2006
Pharm Company: * MGI PHARMA INC
Category: Cancer

Decitabine, sold under the brand name Dacogen, acts as a nucleic acid synthesis inhibitor.[1] It is a medication for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).[2] Chemically, it is a cytidine analog. Contents 1 Medical uses 2 Pharmacology 3 Research 3.1 Atherosclerosis 4 References 5 Further reading 6 External links Medical uses Decitabine is used... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Dacogen 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 59148-046
Labeler:
Otsuka America Pharmaceutical, Inc.
Dacogen 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 62856-600
Labeler:
Eisai Inc.

Popular Topics

Dacogen

Want to hear what MDS patients experience during treatment....